Ex Ante Economic Evaluation of Arg389 Genetically Targeted Treatment with Bucindolol versus Empirical Treatment with Carvedilol in NYHA III/IV Heart Failure
暂无分享,去创建一个
B. Erstad | J. Karnes | M. Slack | I. Abraham | N. Sweitzer | W. Klimecki | Nimer S. Alkhatib | M. Gharaibeh | Kenneth S. Ramos | Christopher S Lee